Shopping Cart 0
Cart Subtotal
USD 0

Specific Proteins - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000

Details

Specific Proteins-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Specific Proteins-Medical Devices Pipeline Assessment, 2018" provides an overview of Specific Proteins currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Specific Proteins pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Specific Proteins under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Specific Proteins under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Specific Proteins Overview 8

3 Products under Development 9

3.1 Specific Proteins-Pipeline Products by Stage of Development 9

3.2 Specific Proteins-Pipeline Products by Territory 10

3.3 Specific Proteins-Pipeline Products by Regulatory Path 11

3.4 Specific Proteins-Pipeline Products by Estimated Approval Date 12

4 Specific Proteins-Pipeline Products under Development by Companies 13

4.1 Specific Proteins Companies-Pipeline Products by Stage of Development 13

4.2 Specific Proteins-Pipeline Products by Stage of Development 14

5 Specific Proteins Companies and Product Overview 16

5.1 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 16

5.2 Amerimmune Company Overview 18

5.3 Analyticon Biotechnologies AG Company Overview 20

5.4 Beckman Coulter Inc Company Overview 25

5.5 China Medical Technologies Inc (Inactive) Company Overview 33

5.6 Colorado State University Company Overview 34

5.7 ELITechGroup Inc Company Overview 35

5.8 Fujirebio Diagnostics Inc Company Overview 36

5.9 Genesis Detection Systems, Inc. Company Overview 37

5.10 Genome Diagnostics Pvt. Ltd. Company Overview 38

5.11 Guanine Inc Company Overview 39

5.12 InDevR Inc Company Overview 40

5.13 Kobe University Company Overview 42

5.14 Ottawa Hospital Research Institute Company Overview 43

5.15 Sebia SA Company Overview 44

5.16 Siemens Healthcare GmbH Company Overview 45

5.17 The Binding Site Group Ltd Company Overview 51

5.18 The Chinese University of Hong Kong Company Overview 52

5.19 University of California Company Overview 53

6 Specific Proteins- Recent Developments 54

6.1 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 54

6.2 Jun 19, 2018: KCAS Bioanalytical and Biomarker Services Welcomes Director of Bioanalytical Discovery Research Services 58

6.3 Jun 13, 2018: Alfa Wassermann Diagnostic Technologies Honored for Delivering 'World-Class' Customer Service 59

6.4 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 59

6.5 Jun 06, 2018: SomaLogic: Translating the Book of Life 60

6.6 Jun 05, 2018: Thermo Fisher Scientific supports the European STATIN trial to evaluate pravastatin in the potential prevention of preeclampsia 60

6.7 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 61

7 Appendix 132

7.1 Methodology 132

7.2 About GlobalData 135

7.3 Contact Us 135

7.4 Disclaimer 135


List Of Figure

1.2 List of Figures

Figure 1: Specific Proteins-Pipeline Products by Stage of Development 9

Figure 2: Specific Proteins-Pipeline Products by Territory 10

Figure 3: Specific Proteins-Pipeline Products by Regulatory Path 11

Figure 4: Specific Proteins-Pipeline Products by Estimated Approval Date 12


List Of Table

1.1 List of Tables

Table 1: Specific Proteins-Pipeline Products by Stage of Development 9

Table 2: Specific Proteins-Pipeline Products by Territory 10

Table 3: Specific Proteins-Pipeline Products by Regulatory Path 11

Table 4: Specific Proteins-Pipeline Products by Estimated Approval Date 12

Table 5: Specific Proteins Companies-Pipeline Products by Stage of Development 13

Table 6: Specific Proteins-Pipeline Products by Stage of Development 14

Table 7: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 8: ACE Axcel System-Lp(a) Assay-Product Status 16

Table 9: ACE Axcel System-Lp(a) Assay-Product Description 16

Table 10: ACE Axcel System-Microalbumin Assay-Product Status 17

Table 11: ACE Axcel System-Microalbumin Assay-Product Description 17

Table 12: ACE Axcel System-Transferrin Assay-Product Status 17

Table 13: ACE Axcel System-Transferrin Assay-Product Description 17

Table 14: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 18

Table 15: FoxP3 Protein Expression Assay-Product Status 18

Table 16: FoxP3 Protein Expression Assay-Product Description 18

Table 17: Wiscott-Aldrich Protein Expression Assay-Product Status 19

Table 18: Wiscott-Aldrich Protein Expression Assay-Product Description 19

Table 19: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20

Table 20: Turbitex C 3c Reagent-Product Status 20

Table 21: Turbitex C 3c Reagent-Product Description 21

Table 22: Turbitex C 4 Reagent-Product Status 21

Table 23: Turbitex C 4 Reagent-Product Description 22

Table 24: Turbitex CRP Reagent-Product Status 22

Table 25: Turbitex CRP Reagent-Product Description 23

Table 26: Turbitex CRP Ultra Reagent-Product Status 23

Table 27: Turbitex CRP Ultra Reagent-Product Description 24

Table 28: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 29: Access-sFlt-1 Assay-Product Status 26

Table 30: Access-sFlt-1 Assay-Product Description 26

Table 31: UniCel DxC 600i Synchron Access Clinical System-sFlt-1 Assay-Product Status 26

Table 32: UniCel DxC 600i Synchron Access Clinical System-sFlt-1 Assay-Product Description 26

Table 33: UniCel DxC 680i Synchron Access Clinical System-PlGF Assay-Product Status 27

Table 34: UniCel DxC 680i Synchron Access Clinical System-PlGF Assay-Product Description 27

Table 35: UniCel DxC 680i Synchron Access Clinical System-sFlt-1 Assay-Product Status 27

Table 36: UniCel DxC 680i Synchron Access Clinical System-sFlt-1 Assay-Product Description 27

Table 37: UniCel DxC 860i Synchron Access Clinical System-PlGF Assay-Product Status 28

Table 38: UniCel DxC 860i Synchron Access Clinical System-PlGF Assay-Product Description 28

Table 39: UniCel DxC 860i Synchron Access Clinical System-sFlt-1 Assay-Product Status 28

Table 40: UniCel DxC 860i Synchron Access Clinical System-sFlt-1 Assay-Product Description 28

Table 41: UniCel DxC 880i Synchron Access Clinical System-PlGF Assay-Product Status 29

Table 42: UniCel DxC 880i Synchron Access Clinical System-PlGF Assay-Product Description 29

Table 43: UniCel DxC 880i Synchron Access Clinical System-sFlt-1 Assay-Product Status 29

Table 44: UniCel DxC 880i Synchron Access Clinical System-sFlt-1 Assay-Product Description 29

Table 45: UniCel DxI 600 Access Immunoassay System-PlGF Assay-Product Status 30

Table 46: UniCel DxI 600 Access Immunoassay System-PlGF Assay-Product Description 30

Table 47: UniCel DxI 600 Access Immunoassay System-sFlt-1 Assay-Product Status 30

Table 48: UniCel DxI 600 Access Immunoassay System-sFlt-1 Assay-Product Description 30

Table 49: UniCel DxI 660i Synchron Access Clinical System-sFlt-1 Assay-Product Status 31

Table 50: UniCel DxI 660i Synchron Access Clinical System-sFlt-1 Assay-Product Description 31

Table 51: UniCel DxI 800 Access Immunoassay System-PlGF Assay-Product Status 31

Table 52: UniCel DxI 800 Access Immunoassay System-PlGF Assay-Product Description 31

Table 53: UniCel DxI 800 Access Immunoassay System-sFlt-1 Assay-Product Status 32

Table 54: UniCel DxI 800 Access Immunoassay System-sFlt-1 Assay-Product Description 32

Table 55: UniCel DxI 860i Synchron Access Clinical System-PlGF Assay-Product Status 32

Table 56: UniCel DxI 860i Synchron Access Clinical System-PlGF Assay-Product Description 32

Table 57: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

Table 58: Diagnostic Assay-Protein 24-Product Status 33

Table 59: Diagnostic Assay-Protein 24-Product Description 33

Table 60: Colorado State University Pipeline Products & Ongoing Clinical Trials Overview 34

Table 61: Unconjugated Ubiquitin Assay-Product Status 34

Table 62: Unconjugated Ubiquitin Assay-Product Description 34

Table 63: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Table 64: Selectra ProM Chemistry System-Microalbumin-Product Status 35

Table 65: Selectra ProM Chemistry System-Microalbumin-Product Description 35

Table 66: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Table 67: Lumipulse G-ApoB48 Assay Kit-Product Status 36

Table 68: Lumipulse G-ApoB48 Assay Kit-Product Description 36

Table 69: Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 70: Rapid Home Test-Albumin-Product Status 37

Table 71: Rapid Home Test-Albumin-Product Description 37

Table 72: Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 73: IFN (gamma) Real Time PCR Kit-Product Status 38

Table 74: IFN (gamma) Real Time PCR Kit-Product Description 38

Table 75: Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 76: Guanine Amplified Assay Kit-Proteins-Product Status 39

Table 77: Guanine Amplified Assay Kit-Proteins-Product Description 39

Table 78: InDevR Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 79: VaxArray-Ebola-Product Status 40

Table 80: VaxArray-Ebola-Product Description 40

Table 81: VaxArray-Zika Virus-Product Status 41

Table 82: VaxArray-Zika Virus-Product Description 41

Table 83: Kobe University Pipeline Products & Ongoing Clinical Trials Overview 42

Table 84: Diagnostic Kit-Bilirubin-Product Status 42

Table 85: Diagnostic Kit-Bilirubin-Product Description 42

Table 86: Ottawa Hospital Research Institute Pipeline Products & Ongoing Clinical Trials Overview 43

Table 87: IGFBP-4 Blood Test-Product Status 43

Table 88: IGFBP-4 Blood Test-Product Description 43

Table 89: Sebia SA Pipeline Products & Ongoing Clinical Trials Overview 44

Table 90: Capillarys 3 Tera Assay-Protein HR-Product Status 44

Table 91: Capillarys 3 Tera Assay-Protein HR-Product Description 44

Table 92: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 45

Table 93: ADVIA Centaur CP Immunoassay System-PIGF Assay-Product Status 45

Table 94: ADVIA Centaur CP Immunoassay System-PIGF Assay-Product Description 46

Table 95: ADVIA Centaur CP Immunoassay System-sFLT-1 Assay-Product Status 46

Table 96: ADVIA Centaur CP Immunoassay System-sFLT-1 Assay-Product Description 46

Table 97: ADVIA Centaur XP Immunoassay System-PIGF Assay-Product Status 47

Table 98: ADVIA Centaur XP Immunoassay System-PIGF Assay-Product Description 47

Table 99: ADVIA Centaur XP Immunoassay System-sFLT-1 Assay-Product Status 47

Table 100: ADVIA Centaur XP Immunoassay System-sFLT-1 Assay-Product Description 48

Table 101: ADVIA Centaur XPT Immunoassay System-PIGF Assay-Product Status 48

Table 102: ADVIA Centaur XPT Immunoassay System-PIGF Assay-Product Description 48

Table 103: ADVIA Centaur XPT Immunoassay System-sFLT-1 Assay-Product Status 49

Table 104: ADVIA Centaur XPT Immunoassay System-sFLT-1 Assay-Product Description 49

Table 105: PLGF Biomarker-Based Preeclampsia Diagnostic Assay-Product Status 49

Table 106: PLGF Biomarker-Based Preeclampsia Diagnostic Assay-Product Description 50

Table 107: SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay-Product Status 50

Table 108: SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay-Product Description 50

Table 109: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Table 110: Optilite-Lipoprotein (A) Test-Product Status 51

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Alfa Wassermann Diagnostic Technologies, LLC, ACE Axcel System - Lp(a) Assay; Alfa Wassermann Diagnostic Technologies, LLC, ACE Axcel System - Microalbumin Assay; Alfa Wassermann Diagnostic Technologies, LLC, ACE Axcel System - Transferrin Assay; Amerimmune, FoxP3 Protein Expression Assay; Amerimmune, Wiscott-Aldrich Protein Expression Assay; Analyticon Biotechnologies AG, Turbitex C 3c Reagent; Analyticon Biotechnologies AG, Turbitex C 4 Reagent; Analyticon Biotechnologies AG, Turbitex CRP Reagent; Analyticon Biotechnologies AG, Turbitex CRP Ultra Reagent; Beckman Coulter Inc, Access - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 600i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 680i Synchron Access Clinical System - PlGF Assay; Beckman Coulter Inc, UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 860i Synchron Access Clinical System - PlGF Assay; Beckman Coulter Inc, UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 880i Synchron Access Clinical System - PlGF Assay; Beckman Coulter Inc, UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 600 Access Immunoassay System - PlGF Assay; Beckman Coulter Inc, UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 800 Access Immunoassay System - PlGF Assay; Beckman Coulter Inc, UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 860i Synchron Access Clinical System - PlGF Assay; China Medical Technologies Inc (Inactive), Diagnostic Assay - Protein 24; Colorado State University, Unconjugated Ubiquitin Assay; ELITechGroup Inc, Selectra ProM Chemistry System - Microalbumin; Fujirebio Diagnostics Inc, Lumipulse G - ApoB48 Assay Kit; Genesis Detection Systems, Inc., Rapid Home Test - Albumin; Genome Diagnostics Pvt. Ltd., IFN (gamma) Real Time PCR Kit; Guanine Inc, Guanine Amplified Assay Kit - Proteins; InDevR Inc, VaxArray - Ebola; InDevR Inc, VaxArray - Zika Virus; Kobe University, Diagnostic Kit - Bilirubin; Ottawa Hospital Research Institute, IGFBP-4 Blood Test; Sebia SA, Capillarys 3 Tera Assay - Protein HR; Siemens Healthcare GmbH, ADVIA Centaur CP Immunoassay System - PIGF Assay; Siemens Healthcare GmbH, ADVIA Centaur CP Immunoassay System - sFLT-1 Assay; Siemens Healthcare GmbH, ADVIA Centaur XP Immunoassay System - PIGF Assay; Siemens Healthcare GmbH, ADVIA Centaur XP Immunoassay System - sFLT-1 Assay; Siemens Healthcare GmbH, ADVIA Centaur XPT Immunoassay System - PIGF Assay; Siemens Healthcare GmbH, ADVIA Centaur XPT Immunoassay System - sFLT-1 Assay; Siemens Healthcare GmbH, PLGF Biomarker-Based Preeclampsia Diagnostic Assay; Siemens Healthcare GmbH, SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay; The Binding Site Group Ltd, Optilite - Lipoprotein (A) Test; The Chinese University of Hong Kong, Diagnostic Assay - Male Fertility; University of California, Serologic Assay - Brain Ischemia


Companies

Alfa Wassermann Diagnostic Technologies, LLC

Amerimmune

Analyticon Biotechnologies AG

Beckman Coulter Inc

China Medical Technologies Inc

Colorado State University

ELITechGroup Inc

Fujirebio Diagnostics Inc

Genesis Detection Systems, Inc.

Genome Diagnostics Pvt. Ltd.

Guanine Inc

InDevR Inc

Kobe University

Ottawa Hospital Research Institute

Sebia SA

Siemens Healthcare GmbH

The Binding Site Group Ltd

The Chinese University of Hong Kong

University of California

Company Profile

Company Profile Title

Specific Proteins-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Specific Proteins-Medical Devices Pipeline Assessment, 2018" provides an overview of Specific Proteins currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Specific Proteins pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Specific Proteins under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Specific Proteins under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Specific Proteins Overview 8

3 Products under Development 9

3.1 Specific Proteins-Pipeline Products by Stage of Development 9

3.2 Specific Proteins-Pipeline Products by Territory 10

3.3 Specific Proteins-Pipeline Products by Regulatory Path 11

3.4 Specific Proteins-Pipeline Products by Estimated Approval Date 12

4 Specific Proteins-Pipeline Products under Development by Companies 13

4.1 Specific Proteins Companies-Pipeline Products by Stage of Development 13

4.2 Specific Proteins-Pipeline Products by Stage of Development 14

5 Specific Proteins Companies and Product Overview 16

5.1 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 16

5.2 Amerimmune Company Overview 18

5.3 Analyticon Biotechnologies AG Company Overview 20

5.4 Beckman Coulter Inc Company Overview 25

5.5 China Medical Technologies Inc (Inactive) Company Overview 33

5.6 Colorado State University Company Overview 34

5.7 ELITechGroup Inc Company Overview 35

5.8 Fujirebio Diagnostics Inc Company Overview 36

5.9 Genesis Detection Systems, Inc. Company Overview 37

5.10 Genome Diagnostics Pvt. Ltd. Company Overview 38

5.11 Guanine Inc Company Overview 39

5.12 InDevR Inc Company Overview 40

5.13 Kobe University Company Overview 42

5.14 Ottawa Hospital Research Institute Company Overview 43

5.15 Sebia SA Company Overview 44

5.16 Siemens Healthcare GmbH Company Overview 45

5.17 The Binding Site Group Ltd Company Overview 51

5.18 The Chinese University of Hong Kong Company Overview 52

5.19 University of California Company Overview 53

6 Specific Proteins- Recent Developments 54

6.1 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 54

6.2 Jun 19, 2018: KCAS Bioanalytical and Biomarker Services Welcomes Director of Bioanalytical Discovery Research Services 58

6.3 Jun 13, 2018: Alfa Wassermann Diagnostic Technologies Honored for Delivering 'World-Class' Customer Service 59

6.4 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 59

6.5 Jun 06, 2018: SomaLogic: Translating the Book of Life 60

6.6 Jun 05, 2018: Thermo Fisher Scientific supports the European STATIN trial to evaluate pravastatin in the potential prevention of preeclampsia 60

6.7 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 61

7 Appendix 132

7.1 Methodology 132

7.2 About GlobalData 135

7.3 Contact Us 135

7.4 Disclaimer 135


List Of Figure

1.2 List of Figures

Figure 1: Specific Proteins-Pipeline Products by Stage of Development 9

Figure 2: Specific Proteins-Pipeline Products by Territory 10

Figure 3: Specific Proteins-Pipeline Products by Regulatory Path 11

Figure 4: Specific Proteins-Pipeline Products by Estimated Approval Date 12


List Of Table

1.1 List of Tables

Table 1: Specific Proteins-Pipeline Products by Stage of Development 9

Table 2: Specific Proteins-Pipeline Products by Territory 10

Table 3: Specific Proteins-Pipeline Products by Regulatory Path 11

Table 4: Specific Proteins-Pipeline Products by Estimated Approval Date 12

Table 5: Specific Proteins Companies-Pipeline Products by Stage of Development 13

Table 6: Specific Proteins-Pipeline Products by Stage of Development 14

Table 7: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 8: ACE Axcel System-Lp(a) Assay-Product Status 16

Table 9: ACE Axcel System-Lp(a) Assay-Product Description 16

Table 10: ACE Axcel System-Microalbumin Assay-Product Status 17

Table 11: ACE Axcel System-Microalbumin Assay-Product Description 17

Table 12: ACE Axcel System-Transferrin Assay-Product Status 17

Table 13: ACE Axcel System-Transferrin Assay-Product Description 17

Table 14: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 18

Table 15: FoxP3 Protein Expression Assay-Product Status 18

Table 16: FoxP3 Protein Expression Assay-Product Description 18

Table 17: Wiscott-Aldrich Protein Expression Assay-Product Status 19

Table 18: Wiscott-Aldrich Protein Expression Assay-Product Description 19

Table 19: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20

Table 20: Turbitex C 3c Reagent-Product Status 20

Table 21: Turbitex C 3c Reagent-Product Description 21

Table 22: Turbitex C 4 Reagent-Product Status 21

Table 23: Turbitex C 4 Reagent-Product Description 22

Table 24: Turbitex CRP Reagent-Product Status 22

Table 25: Turbitex CRP Reagent-Product Description 23

Table 26: Turbitex CRP Ultra Reagent-Product Status 23

Table 27: Turbitex CRP Ultra Reagent-Product Description 24

Table 28: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 29: Access-sFlt-1 Assay-Product Status 26

Table 30: Access-sFlt-1 Assay-Product Description 26

Table 31: UniCel DxC 600i Synchron Access Clinical System-sFlt-1 Assay-Product Status 26

Table 32: UniCel DxC 600i Synchron Access Clinical System-sFlt-1 Assay-Product Description 26

Table 33: UniCel DxC 680i Synchron Access Clinical System-PlGF Assay-Product Status 27

Table 34: UniCel DxC 680i Synchron Access Clinical System-PlGF Assay-Product Description 27

Table 35: UniCel DxC 680i Synchron Access Clinical System-sFlt-1 Assay-Product Status 27

Table 36: UniCel DxC 680i Synchron Access Clinical System-sFlt-1 Assay-Product Description 27

Table 37: UniCel DxC 860i Synchron Access Clinical System-PlGF Assay-Product Status 28

Table 38: UniCel DxC 860i Synchron Access Clinical System-PlGF Assay-Product Description 28

Table 39: UniCel DxC 860i Synchron Access Clinical System-sFlt-1 Assay-Product Status 28

Table 40: UniCel DxC 860i Synchron Access Clinical System-sFlt-1 Assay-Product Description 28

Table 41: UniCel DxC 880i Synchron Access Clinical System-PlGF Assay-Product Status 29

Table 42: UniCel DxC 880i Synchron Access Clinical System-PlGF Assay-Product Description 29

Table 43: UniCel DxC 880i Synchron Access Clinical System-sFlt-1 Assay-Product Status 29

Table 44: UniCel DxC 880i Synchron Access Clinical System-sFlt-1 Assay-Product Description 29

Table 45: UniCel DxI 600 Access Immunoassay System-PlGF Assay-Product Status 30

Table 46: UniCel DxI 600 Access Immunoassay System-PlGF Assay-Product Description 30

Table 47: UniCel DxI 600 Access Immunoassay System-sFlt-1 Assay-Product Status 30

Table 48: UniCel DxI 600 Access Immunoassay System-sFlt-1 Assay-Product Description 30

Table 49: UniCel DxI 660i Synchron Access Clinical System-sFlt-1 Assay-Product Status 31

Table 50: UniCel DxI 660i Synchron Access Clinical System-sFlt-1 Assay-Product Description 31

Table 51: UniCel DxI 800 Access Immunoassay System-PlGF Assay-Product Status 31

Table 52: UniCel DxI 800 Access Immunoassay System-PlGF Assay-Product Description 31

Table 53: UniCel DxI 800 Access Immunoassay System-sFlt-1 Assay-Product Status 32

Table 54: UniCel DxI 800 Access Immunoassay System-sFlt-1 Assay-Product Description 32

Table 55: UniCel DxI 860i Synchron Access Clinical System-PlGF Assay-Product Status 32

Table 56: UniCel DxI 860i Synchron Access Clinical System-PlGF Assay-Product Description 32

Table 57: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

Table 58: Diagnostic Assay-Protein 24-Product Status 33

Table 59: Diagnostic Assay-Protein 24-Product Description 33

Table 60: Colorado State University Pipeline Products & Ongoing Clinical Trials Overview 34

Table 61: Unconjugated Ubiquitin Assay-Product Status 34

Table 62: Unconjugated Ubiquitin Assay-Product Description 34

Table 63: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Table 64: Selectra ProM Chemistry System-Microalbumin-Product Status 35

Table 65: Selectra ProM Chemistry System-Microalbumin-Product Description 35

Table 66: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Table 67: Lumipulse G-ApoB48 Assay Kit-Product Status 36

Table 68: Lumipulse G-ApoB48 Assay Kit-Product Description 36

Table 69: Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 70: Rapid Home Test-Albumin-Product Status 37

Table 71: Rapid Home Test-Albumin-Product Description 37

Table 72: Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 73: IFN (gamma) Real Time PCR Kit-Product Status 38

Table 74: IFN (gamma) Real Time PCR Kit-Product Description 38

Table 75: Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 76: Guanine Amplified Assay Kit-Proteins-Product Status 39

Table 77: Guanine Amplified Assay Kit-Proteins-Product Description 39

Table 78: InDevR Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 79: VaxArray-Ebola-Product Status 40

Table 80: VaxArray-Ebola-Product Description 40

Table 81: VaxArray-Zika Virus-Product Status 41

Table 82: VaxArray-Zika Virus-Product Description 41

Table 83: Kobe University Pipeline Products & Ongoing Clinical Trials Overview 42

Table 84: Diagnostic Kit-Bilirubin-Product Status 42

Table 85: Diagnostic Kit-Bilirubin-Product Description 42

Table 86: Ottawa Hospital Research Institute Pipeline Products & Ongoing Clinical Trials Overview 43

Table 87: IGFBP-4 Blood Test-Product Status 43

Table 88: IGFBP-4 Blood Test-Product Description 43

Table 89: Sebia SA Pipeline Products & Ongoing Clinical Trials Overview 44

Table 90: Capillarys 3 Tera Assay-Protein HR-Product Status 44

Table 91: Capillarys 3 Tera Assay-Protein HR-Product Description 44

Table 92: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 45

Table 93: ADVIA Centaur CP Immunoassay System-PIGF Assay-Product Status 45

Table 94: ADVIA Centaur CP Immunoassay System-PIGF Assay-Product Description 46

Table 95: ADVIA Centaur CP Immunoassay System-sFLT-1 Assay-Product Status 46

Table 96: ADVIA Centaur CP Immunoassay System-sFLT-1 Assay-Product Description 46

Table 97: ADVIA Centaur XP Immunoassay System-PIGF Assay-Product Status 47

Table 98: ADVIA Centaur XP Immunoassay System-PIGF Assay-Product Description 47

Table 99: ADVIA Centaur XP Immunoassay System-sFLT-1 Assay-Product Status 47

Table 100: ADVIA Centaur XP Immunoassay System-sFLT-1 Assay-Product Description 48

Table 101: ADVIA Centaur XPT Immunoassay System-PIGF Assay-Product Status 48

Table 102: ADVIA Centaur XPT Immunoassay System-PIGF Assay-Product Description 48

Table 103: ADVIA Centaur XPT Immunoassay System-sFLT-1 Assay-Product Status 49

Table 104: ADVIA Centaur XPT Immunoassay System-sFLT-1 Assay-Product Description 49

Table 105: PLGF Biomarker-Based Preeclampsia Diagnostic Assay-Product Status 49

Table 106: PLGF Biomarker-Based Preeclampsia Diagnostic Assay-Product Description 50

Table 107: SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay-Product Status 50

Table 108: SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay-Product Description 50

Table 109: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Table 110: Optilite-Lipoprotein (A) Test-Product Status 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Alfa Wassermann Diagnostic Technologies, LLC, ACE Axcel System - Lp(a) Assay; Alfa Wassermann Diagnostic Technologies, LLC, ACE Axcel System - Microalbumin Assay; Alfa Wassermann Diagnostic Technologies, LLC, ACE Axcel System - Transferrin Assay; Amerimmune, FoxP3 Protein Expression Assay; Amerimmune, Wiscott-Aldrich Protein Expression Assay; Analyticon Biotechnologies AG, Turbitex C 3c Reagent; Analyticon Biotechnologies AG, Turbitex C 4 Reagent; Analyticon Biotechnologies AG, Turbitex CRP Reagent; Analyticon Biotechnologies AG, Turbitex CRP Ultra Reagent; Beckman Coulter Inc, Access - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 600i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 680i Synchron Access Clinical System - PlGF Assay; Beckman Coulter Inc, UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 860i Synchron Access Clinical System - PlGF Assay; Beckman Coulter Inc, UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxC 880i Synchron Access Clinical System - PlGF Assay; Beckman Coulter Inc, UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 600 Access Immunoassay System - PlGF Assay; Beckman Coulter Inc, UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 800 Access Immunoassay System - PlGF Assay; Beckman Coulter Inc, UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay; Beckman Coulter Inc, UniCel DxI 860i Synchron Access Clinical System - PlGF Assay; China Medical Technologies Inc (Inactive), Diagnostic Assay - Protein 24; Colorado State University, Unconjugated Ubiquitin Assay; ELITechGroup Inc, Selectra ProM Chemistry System - Microalbumin; Fujirebio Diagnostics Inc, Lumipulse G - ApoB48 Assay Kit; Genesis Detection Systems, Inc., Rapid Home Test - Albumin; Genome Diagnostics Pvt. Ltd., IFN (gamma) Real Time PCR Kit; Guanine Inc, Guanine Amplified Assay Kit - Proteins; InDevR Inc, VaxArray - Ebola; InDevR Inc, VaxArray - Zika Virus; Kobe University, Diagnostic Kit - Bilirubin; Ottawa Hospital Research Institute, IGFBP-4 Blood Test; Sebia SA, Capillarys 3 Tera Assay - Protein HR; Siemens Healthcare GmbH, ADVIA Centaur CP Immunoassay System - PIGF Assay; Siemens Healthcare GmbH, ADVIA Centaur CP Immunoassay System - sFLT-1 Assay; Siemens Healthcare GmbH, ADVIA Centaur XP Immunoassay System - PIGF Assay; Siemens Healthcare GmbH, ADVIA Centaur XP Immunoassay System - sFLT-1 Assay; Siemens Healthcare GmbH, ADVIA Centaur XPT Immunoassay System - PIGF Assay; Siemens Healthcare GmbH, ADVIA Centaur XPT Immunoassay System - sFLT-1 Assay; Siemens Healthcare GmbH, PLGF Biomarker-Based Preeclampsia Diagnostic Assay; Siemens Healthcare GmbH, SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay; The Binding Site Group Ltd, Optilite - Lipoprotein (A) Test; The Chinese University of Hong Kong, Diagnostic Assay - Male Fertility; University of California, Serologic Assay - Brain Ischemia


Companies

Alfa Wassermann Diagnostic Technologies, LLC

Amerimmune

Analyticon Biotechnologies AG

Beckman Coulter Inc

China Medical Technologies Inc

Colorado State University

ELITechGroup Inc

Fujirebio Diagnostics Inc

Genesis Detection Systems, Inc.

Genome Diagnostics Pvt. Ltd.

Guanine Inc

InDevR Inc

Kobe University

Ottawa Hospital Research Institute

Sebia SA

Siemens Healthcare GmbH

The Binding Site Group Ltd

The Chinese University of Hong Kong

University of California